Sepsis Research Blood Sample Collection Services

This notice of intent authorizes the Defense Health Agency to extend an existing contract and convert it to a cost‑type Research & Development award for the collection of blood samples and longitudinal clinical data from septic and non‑septic burn patients. The goal is to support the SeptiBurnAlert program by providing specimens and data for biomarker validation. The award will be issued on a sole‑source basis to Medstar Health Research Institute (MHRI), which is already conducting the collection under an approved IRB protocol. • Extend and restructure a Firm‑Fixed‑Price contract into a cost‑type R&D contract. • Collect blood samples from septic and non‑septic burn patients, including longitudinal clinical data. • Support biomarker refinement and validation for the SeptiBurnAlert program. • Sole‑source award to MHRI; capability statements due 10 am EST on October 15 2026.